A structural basis for mutational inactivation of the tumour suppressor Smad4

Nature

Volumn 388, Issue 6637, 1997, Pages 87-93

  Shi, Yigong ^a   Hata, Akiko ^a   Lo, Roger S ^a   Massagué, Joan ^a   Pavletich, Nikola P ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARBOXY TERMINAL SEQUENCE; EFFECTOR CELL; GENE ACTIVATION; GENE DISRUPTION; GENE MUTATION; GENE STRUCTURE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DNA-BINDING PROTEINS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SMAD4 PROTEIN; TRANS-ACTIVATORS;

EID: 0030837455     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/40431     Document Type: Article

References (30)

1. Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271, 350-353 (1996).
2. Schutte, M. et al. DPC4 gene in various tumor types. Cancer Res. 56, 2527-2530 (1996).
3. Kim, S. K. et al. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56, 2519-2521 (1996).
4. Nagatake, M. et al. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 56, 2718-2720 (1996).
5. Massague, J. TGF-β signalling: receptors, transducers, and mad proteins. Cell 85, 947-950 (1996).
6. Derynck, R. et al. Nomenclature: vertebrate mediators of TGFβ family signals. Cell 87, 173 (1996).
7. Derynck, R. & Zhang, Y. Intracellular signalling: the Mad way to do it. Curr. Biol. 6, 1226-1229 (1996).
8. Zhang, Y., Feng, X.-H., Wu, R.-Y. & Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172 (1996).
9. Lagna, G., Hata, A., Hemmati-Brivanlou, A. & Massagué, J. Partnership between SPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383, 832-836 (1996).
10. Yingling, J. M. et al. Mammalian dwarfins are phosphorylated in response to transforming growth factor β and are implicated in control of cell growth. Proc. Natl Acad. Sci. USA 93, 8940-8944 (1996).
11. Hoodless, P. A. et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489-500 (1996).
12. Eppert, K. et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552 (1996).
13. Lechleider, R. J., de Caestecker, M. P., Dehejia, A., Polymeropoulos, M. H. & Roberts, A. B. Serine phosphorylation, chromosomal localization, and transforming growth factor-β signal transduction by human bsp-1. J. Biol. Chem. 271, 17617-17620 (1996).
14. Lin, F. et al. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623 (1996).
15. Hata, A., Lo, R. S., Wotton, D. & Massagué, J. Mutations increasing autoinhibition inactivate the tumour suppressors Smad2 and Smad4. Nature 388, 82-87 (1997).
16. Baker, J. C. & Harland, R. M. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880-1889 (1996).
17. Thiagalingam, S. et al. Evaluation of candidate tumour suppressor genes on the chromosome 18 in colorectal cancers. Nature Genet. 13, 343-346 (1996).
18. Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H. & Gelbart, W. M. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139, 1347-1358 (1995).
19. Savage, C. et al. Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl Acad. Sci. USA 93, 790-794 (1996).
20. Stura, E. A. & Wilson, I. A. in Crystallization of Nucleic Acids and Proteins (eds Ducruix, A. & Giege, R.) 99-126 (Oxford Univ. Press, 1992).
21. Sheldrick, G. in Patterson Interpretation and the Use of Macromolecular Delta-F Data (Daresbury, UK, 1991).
22. Collaborative Computational Project, B. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
23. Zhang, K. Y. J. SQUASH-combining constraints for macromolecular phase refinement and extension. Acta Crystallogr. D 49, 213-222 (1993).
24. Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-110 (1991).
25. Brunger, A. T. X-PLOR, a system for crystallography and NMR (Yale Univ. Press, New Haven, CT, 1991).
26. Klaulis, P. J. Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
27. Merrit, E. A. & Murphy, M. E. Raster3D Version 2.0: a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869-873 (1994).
28. Uchida, K. et al. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56, 5583-5585 (1996).
29. Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281-296 (1991).
30. Macias-Silva, M. et al. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signalling. Cell 87, 1215-1224 (1996).